Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma [J Immunothera Cancer, 4, (2016), (28)] DOI:10.1186/s40425-016-0132-2

  • Mira A. Patel
  • , Jennifer E. Kim
  • , Debebe Theodros
  • , Ada Tam
  • , Esteban Velarde
  • , Christina M. Kochel
  • , Brian Francica
  • , Thomas R. Nirschl
  • , Ali Ghasemzadeh
  • , Dimitrios Mathios
  • , Sarah Harris-Bookman
  • , Christopher C. Jackson
  • , Christina Jackson
  • , Xiaobu Ye
  • , Phuoc T. Tran
  • , Betty Tyler
  • , Vladimir Coric
  • , Mark Selby
  • , Henry Brem
  • , Charles G. Drake
  • Drew M. Pardoll, Michael Lim

Research output: Contribution to journalComment/debate

Abstract

Unfortunately, after publication of this article [1], it was noticed that a funding source was not mentioned. Bristol-Myers Squibb was intended to be included in the 'Financial Support' section of the article.

Original languageEnglish
Article number74
JournalJournal for ImmunoTherapy of Cancer
Volume4
Issue number1
DOIs
StatePublished - Nov 4 2016

Fingerprint

Dive into the research topics of 'Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma [J Immunothera Cancer, 4, (2016), (28)] DOI:10.1186/s40425-016-0132-2'. Together they form a unique fingerprint.

Cite this